Cubist Systematic Strategies’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-22,625	Closed	-$146K	–	3261
2023 Q2	$146K	Sell	22,625 -53	-0.2%	-$362	﹤0.01%	2909
2023 Q1	$171K	Sell	22,678 -145,749	-87%	-$1.32M	﹤0.01%	3290
2022 Q4	$1.71M	Sell	168,427 -415,554	-71%	-$4.8M	0.01%	1984
2022 Q3	$5.78M	Buy	583,981 +188,649	+48%	+$2.07M	0.04%	935
2022 Q2	$4.21M	Buy	395,332 +149,029	+61%	+$1.26M	0.03%	1147
2022 Q1	$2.4M	Sell	246,303 -16,383	-6%	-$155K	0.02%	1330
2021 Q4	$3.76M	Buy	262,686 +225,812	+612%	+$3.43M	0.04%	852
2021 Q3	$739K	Sell	36,874 -223,485	-86%	-$3.95M	0.01%	1755
2021 Q2	$5.73M	Buy	260,359 +221,809	+575%	+$6.12M	0.06%	456
2021 Q1	$1.31M	Buy	+38,550	New	+$1.54M	0.02%	1350